BioNADrx Holdings, Inc. — Form D
BioNADrx Holdings, Inc. of JOHNSON CITY, TN, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-30. The offering totals $10.0M, of which $125K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-01-30
- Form: D
- Accession: 0002009791-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $125K
- Remaining: $9.9M
- Investors: 1
- Date of first sale: 2024-01-30
- Revenue range: Decline to Disclose
- SEC file number: 021-503839
Issuer
- Name: BioNADrx Holdings, Inc.
- CIK: 0002009791
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 207 N. BOONE STREET, SUITE 15, JOHNSON CITY, TN, 37604
- Phone: (216) 470-3047
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Wendy Kormac | Director | JOHNSON CITY, TN |
| Phillip Mansour | Director | JOHNSON CITY, TN |
| Filip Pinter | Director | JOHNSON CITY, TN |
| Wendy Kormac | Executive Officer | JOHNSON CITY, TN |
| Filip Pinter | Executive Officer | JOHNSON CITY, TN |
More